Joanna Fowler
#29,946
Most Influential Person Now
American chemist
Joanna Fowler's AcademicInfluence.com Rankings
Download Badge
Chemistry
Joanna Fowler's Degrees
- PhD Chemistry University of Colorado Boulder
Why Is Joanna Fowler Influential?
(Suggest an Edit or Addition)According to Wikipedia, Joanna Sigfred Fowler is a scientist emeritus at the U.S. Department of Energy's Brookhaven National Laboratory in New York. She served as professor of psychiatry at Mount Sinai School of Medicine and director of Brookhaven's Radiotracer Chemistry, Instrumentation and Biological Imaging Program. Fowler studied the effect of disease, drugs, and aging on the human brain and radiotracers in brain chemistry. She has received many awards for her pioneering work, including the National Medal of Science.
Joanna Fowler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Brain dopamine and obesity (2001) (1695)
- Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data (1996) (1457)
- Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects (1990) (1398)
- Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. (2000) (1221)
- Dopamine in drug abuse and addiction: results from imaging studies and treatment implications (2004) (1167)
- The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane (1979) (1139)
- Cocaine Cues and Dopamine in Dorsal Striatum: Mechanism of Craving in Cocaine Addiction (2006) (1102)
- Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. (2001) (936)
- Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. (2001) (911)
- Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers (1993) (905)
- Imaging dopamine's role in drug abuse and addiction (2009) (890)
- Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. (1998) (862)
- Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects (1997) (825)
- The addicted human brain: insights from imaging studies. (2003) (825)
- Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. (1998) (820)
- Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology (2008) (756)
- Addiction: Beyond dopamine reward circuitry (2011) (746)
- Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain (2001) (730)
- Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence (2001) (684)
- Relationship between subjective effects of cocaine and dopamine transporter occupancy (1997) (641)
- Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) (2001) (627)
- Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. (1978) (606)
- The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies (2004) (604)
- Decreases in dopamine receptors but not in dopamine transporters in alcoholics. (1996) (601)
- A FLUORINATED GLUCOSE ANALOG, 2‐FLUORO-2‐DEOXY-D‐GLUCOSE (F‐18): NONTOXIC TRACER FOR RAPID TUMOR DETECTION (1980) (562)
- Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. (1995) (559)
- Hippocampal formation glucose metabolism and volume losses in MCI and AD (2001) (545)
- Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors (2008) (526)
- Similarity Between Obesity and Drug Addiction as Assessed by Neurofunctional Imaging (2004) (516)
- Role of Dopamine, the Frontal Cortex and Memory Circuits in Drug Addiction: Insight from Imaging Studies (2002) (509)
- Evaluating dopamine reward pathway in ADHD: clinical implications. (2009) (491)
- Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. (2009) (485)
- Addiction circuitry in the human brain. (2012) (471)
- “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect (2002) (465)
- Food and drug reward: overlapping circuits in human obesity and addiction. (2012) (461)
- Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose (1985) (452)
- Changes in brain glucose metabolism in cocaine dependence and withdrawal. (1991) (448)
- Profound Decreases in Dopamine Release in Striatum in Detoxified Alcoholics: Possible Orbitofrontal Involvement (2007) (446)
- Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. (1999) (428)
- Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. (1999) (413)
- Effects of chronic cocaine abuse on postsynaptic dopamine receptors. (1990) (413)
- Long‐Term frontal brain metabolic changes in cocaine abusers (1992) (412)
- Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose (1978) (410)
- Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit (2010) (409)
- Exposure to appetitive food stimuli markedly activates the human brain (2004) (394)
- Imaging endogenous dopamine competition with [11C]raclopride in the human brain (1994) (391)
- Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. (1999) (384)
- Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. (2007) (362)
- Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. (1987) (351)
- Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. (2002) (347)
- Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway (2010) (343)
- Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex (2004) (342)
- Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder (2005) (340)
- Regional brain metabolic activation during craving elicited by recall of previous drug experiences. (1999) (337)
- Brain monoamine oxidase A inhibition in cigarette smokers. (1996) (331)
- Mechanism of action of methylphenidate: Insights from PET imaging studies (2002) (322)
- Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. (2007) (319)
- Inverse Association Between BMI and Prefrontal Metabolic Activity in Healthy Adults (2009) (317)
- High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. (2006) (314)
- Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. (2011) (314)
- Activation of Orbital and Medial Prefrontal Cortex by Methylphenidate in Cocaine-Addicted Subjects But Not in Controls: Relevance to Addiction (2005) (304)
- Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications (2002) (304)
- Mapping cocaine binding sites in human and baboon brain in vivo (1989) (303)
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels (1993) (299)
- Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. (2000) (298)
- Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans (1999) (296)
- Expectation Enhances the Regional Brain Metabolic and the Reinforcing Effects of Stimulants in Cocaine Abusers (2003) (290)
- Gastric distention activates satiety circuitry in the human brain (2008) (288)
- The role of dopamine in motivation for food in humans: implications for obesity (2002) (286)
- Cognitive control of drug craving inhibits brain reward regions in cocaine abusers (2010) (284)
- Dopamine D2 Receptor Availability in Opiate-Dependent Subjects before and after Naloxone-Precipitated Withdrawal (1997) (272)
- Enhanced Striatal Dopamine Release During Food Stimulation in Binge Eating Disorder (2011) (269)
- Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study (2002) (267)
- Dopamine transporters decrease with age. (1996) (266)
- Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. (2004) (265)
- Imaging the Addicted Human Brain (2007) (262)
- Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia. (1989) (261)
- PET evaluation of the dopamine system of the human brain. (1996) (255)
- Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. (2001) (244)
- Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. (2004) (240)
- Brain dopamine transporter levels in treatment and drug naïve adults with ADHD (2007) (239)
- Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. (1984) (236)
- Monoamine oxidase and cigarette smoking. (2003) (234)
- Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. (1977) (233)
- Brain dopamine is associated with eating behaviors in humans. (2003) (231)
- Brain Monoamine Oxidase A Activity Predicts Trait Aggression (2008) (227)
- Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues (2008) (220)
- Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation (2009) (217)
- Decreased dopamine transporters with age in healthy human subjects (1994) (217)
- Age-Related Increases in Brain Monoamine Oxidase B in Living Healthy Human Subjects (1997) (217)
- Decreased brain dopaminergic transporters in HIV-associated dementia patients. (2004) (211)
- Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. (1982) (206)
- Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder (2012) (202)
- Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. (1993) (194)
- Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies (2002) (192)
- Evidence That Sleep Deprivation Downregulates Dopamine D2R in Ventral Striatum in the Human Brain (2012) (189)
- A novel strategy for the treatment of cocaine addiction (1998) (187)
- Recovery of brain glucose metabolism in detoxified alcoholics. (1994) (186)
- Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. (1999) (185)
- Acute effects of ethanol on regional brain glucose metabolism and transport (1990) (183)
- Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging (1998) (179)
- Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique. (1981) (178)
- A Strategy for Removing the Bias in the Graphical Analysis Method (2001) (177)
- Impairment of attentional networks after 1 night of sleep deprivation. (2009) (177)
- Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity (2014) (176)
- Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study (2002) (175)
- Positron Emission Tomography in the Study of Aging and Senile Dementia (1980) (175)
- Positron emission tomographic studies of aging and Alzheimer disease. (1983) (175)
- Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. (1997) (173)
- Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. (2000) (167)
- Decreased brain metabolism in neurologically intact healthy alcoholics. (1992) (167)
- Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3 Receptors in the Human Brain (2008) (166)
- Effects of Blood Flow on [11C]Raclopride Binding in the Brain: Model Simulations and Kinetic Analysis of PET Data (1994) (166)
- Addiction changes orbitofrontal gyrus function: involvement in response inhibition (2001) (163)
- A feedback regulatory loop between G3P and lipid transfer proteins DIR1 and AZI1 mediates azelaic-acid-induced systemic immunity. (2013) (160)
- Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry (2006) (160)
- Imaging of Brain Dopamine Pathways: Implications for Understanding Obesity (2009) (158)
- Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. (1996) (157)
- Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping. (1995) (155)
- PET and drug research and development. (1999) (152)
- Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawal (1994) (150)
- Working Against Time: Rapid Radiotracer Synthesis and Imaging the Human Brain (1997) (145)
- Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain (1997) (144)
- Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse (2008) (142)
- Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol (1996) (141)
- Initial and subsequent approach for the synthesis of 18FDG. (2002) (140)
- PET studies of the effects of aerobic exercise on human striatal dopamine release. (2000) (139)
- Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients (1988) (139)
- Dopamine Transporters in Striatum Correlate with Deactivation in the Default Mode Network during Visuospatial Attention (2009) (138)
- Use of 2-Deoxy-D[1-11C]Glucose for the Determination of Local Cerebral Glucose Metabolism in Humans: Variation within and between Subjects (1982) (136)
- Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans (1999) (135)
- Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications (2010) (132)
- Turnover of Brain Monoamine Oxidase Measured In Vivo by Positron Emission Tomography Using l‐[11C]Deprenyl (1987) (130)
- Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine (2006) (128)
- Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder (2013) (128)
- Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls (2011) (128)
- A new PET ligand for the dopamine transporter: studies in the human brain. (1995) (127)
- Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. (1993) (127)
- Cocaine addiction: hypothesis derived from imaging studies with PET. (1996) (124)
- DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. (2004) (123)
- One-pot, direct incorporation of [11C]CO2 into carbamates. (2009) (123)
- Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. (2007) (122)
- GABAergic attenuation of cocaine‐induced dopamine release and locomotor activity (1997) (120)
- Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. (1977) (119)
- Decreased cerebral response to inhibitory neurotransmission in alcoholics. (1993) (117)
- Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. (1998) (116)
- Enhanced resting activity of the oral somatosensory cortex in obese subjects (2002) (116)
- Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". (1999) (115)
- Evidence That Brain MAO A Activity Does Not Correspond to MAO A Genotype in Healthy Male Subjects (2007) (112)
- Mapping muscarinic receptors in human and baboon brain using [N‐11C‐methyl]‐benztropine (1990) (112)
- A new improved synthesis of 2-deoxy-2-[18F]fluoro-d-glucose from 18F-labeled acetyl hypofluorite. (1982) (110)
- Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men (2012) (107)
- Effects of endogenous dopamine on measures of [18F]N‐methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons (1991) (106)
- Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers (2014) (106)
- A novel approach for imaging brain–behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator (2007) (106)
- Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain (2015) (106)
- Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. (1994) (103)
- Dynamic functional imaging of brain glucose utilization using fPET-FDG (2014) (103)
- Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography (1985) (102)
- Thallium in organic synthesis. XXII. Electrophilic aromatic thallation using thallium(III) trifluoroacetate. Simple synthesis of aromatic iodides (1971) (102)
- Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task (2008) (101)
- Low doses of alcohol substantially decrease glucose metabolism in the human brain (2006) (101)
- Positron Emission Tomography and Computed Tomography Assessments of the Aging Human Brain (1984) (99)
- Unique distribution of aromatase in the human brain: In vivo studies with PET and [N‐methyl‐11C]vorozole (2010) (99)
- Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic Tracers (1987) (99)
- Positive Emotionality is Associated with Baseline Metabolism in Orbitofrontal Cortex and in Regions of the Default Network (2011) (98)
- Regional brain metabolism during alcohol intoxication. (2000) (96)
- Amphetamine induced decreases in (18F)‐N‐methylspiroperidol binding in the baboon brain using positron emission tomography (PET) (1991) (96)
- Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. (2010) (96)
- [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. (1985) (96)
- Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. (1995) (96)
- Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma (2003) (95)
- Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification. (1997) (94)
- Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine (2008) (94)
- Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects (2006) (93)
- Age‐related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET) (1990) (92)
- 6‐[18F]Fluoro‐A‐85380, a new PET tracer for the nicotinic acetylcholine receptor: Studies in the human brain and in vivo demonstration of specific binding in white matter (2004) (91)
- Dr. Volkow and Associates Reply (1991) (91)
- Reduced Metabolism in Brain “Control Networks” following Cocaine-Cues Exposure in Female Cocaine Abusers (2011) (90)
- Depression of Thalamic Metabolism by Lorazepam Is Associated with Sleepiness (1995) (89)
- Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. (2003) (86)
- Monoamine oxidase: radiotracer development and human studies. (2000) (86)
- Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans (2008) (86)
- Low monoamine oxidase B in peripheral organs in smokers (2003) (86)
- Positron emission tomography and single-photon emission computed tomography in substance abuse research. (2003) (84)
- Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain (2013) (83)
- Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. (2013) (80)
- Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease (1993) (79)
- A shielded synthesis system for production of 2-deoxy-2-[18F]fluoro-D-glucose. (1981) (79)
- Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. (1986) (77)
- Syntheses and Specific Activity Determinations of No-Carrier-Added Fluorine-18-Labeled Neuroleptic Drugs (1985) (77)
- Histone Deacetylase Inhibitor MS-275 Exhibits Poor Brain Penetration: Pharmacokinetic Studies of [11C]MS-275 using Positron Emission Tomography (2010) (75)
- Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. (1995) (75)
- [11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice. (1982) (75)
- Pharmacokinetics and in vivo specificity of [LLC]dl‐threo‐methylphenidate for the presynaptic dopaminergic neuron (1994) (74)
- 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. (1982) (74)
- Translational Neuroimaging: Positron Emission Tomography Studies of Monoamine Oxidase (2005) (73)
- Patterns of metabolic activity in the treatment of schizophrenia (1984) (73)
- The synthesis of 18 F-5-fluorouracil. VII. (1973) (72)
- Neural mechanisms of anger regulation as a function of genetic risk for violence. (2009) (71)
- Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec). (2007) (70)
- Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. (2007) (69)
- Oxygen and sulfur methylation of ambident p-toluenesulfinate anion (1968) (68)
- Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer’s dementia (2001) (68)
- Moderate doses of alcohol disrupt the functional organization of the human brain (2008) (67)
- No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice. (1986) (67)
- Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability (2012) (67)
- Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release (2015) (67)
- Genomic Features of the Human Dopamine Transporter Gene and Its Potential Epigenetic States: Implications for Phenotypic Diversity (2010) (66)
- Distribution and kinetics of carbon-11-cocaine in the human body measured with PET. (1992) (66)
- Evaluating Dopamine Reward Pathway in ADHD (2011) (66)
- Mapping nicotinic acetylcholine receptors with PET (1996) (66)
- [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy. (2001) (65)
- Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations (1998) (65)
- Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain. (1995) (65)
- Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment (2009) (64)
- Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography. (1985) (62)
- Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. (2000) (62)
- Mapping of functional activity in brain with 18F-fluoro-deoxyglucose. (1981) (62)
- Maternal-fetal in vivo imaging: a combined PET and MRI study. (2003) (62)
- Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity. (1997) (62)
- Genotype and Ancestry Modulate Brain's DAT Availability in Healthy Humans (2011) (61)
- A synthesis of 2-deoxy-D-[1-11C]glucose for regional metabolic studies: concise communication. (1981) (61)
- Quantitative autoradiography with radiopharmaceuticals, Part 2: Applications in radiopharmaceutical research: concise communication. (1983) (61)
- Cocaine Increases the Intracellular Calcium Concentration in Brain Independently of Its Cerebrovascular Effects (2006) (59)
- Synthesis of suicide inhibitors of monoamine oxidase: Carbon‐11 labeled clorgyline, L‐deprenyl and D‐deprenyl (1988) (59)
- Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan. (1972) (58)
- Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers (2010) (57)
- Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons. (2010) (57)
- Association of Body Mass and Brain Activation during Gastric Distention: Implications for Obesity (2009) (57)
- Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate. (1999) (57)
- Gender differences in cerebellar metabolism: test-retest reproducibility. (1997) (56)
- Carbon-11 labeled aliphatic amines in lung uptake and metabolism studies: potential for dynamic measurements in vivo. (1976) (56)
- Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain (2014) (56)
- PET Studies of d-Methamphetamine Pharmacokinetics in Primates: Comparison with l-Methamphetamine and (−)-Cocaine (2007) (55)
- Monoamine oxidase: radiotracer chemistry and human studies. (2015) (54)
- Positron emission tomography (PET) studies of dopaminergic/cholinergic interaction in the baboon brain (1990) (54)
- Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. (1994) (54)
- Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration (2004) (53)
- Plasma input function determination for PET using a commercial laboratory robot. (1995) (53)
- BMI Modulates Calorie-Dependent Dopamine Changes in Accumbens from Glucose Intake (2014) (52)
- Synthesis of high specific activity (+)- and (-)-6-[18F]fluoronorepinephrine via the nucleophilic aromatic substitution reaction. (1991) (52)
- Synthesis of high specific activity 6-[18F]fluorodopamine for positron emission tomography studies of sympathetic nervous tissue. (1991) (52)
- Imaging Studies of Cocaine in the Human Brain and Studies of the Cocaine Addict a (1997) (52)
- Rapid Stereoselective Hydrolysis of (+)‐Cocaine in Baboon Plasma Prevents Its Uptake in the Brain: Implications for Behavioral Studies (1990) (52)
- Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. (1998) (51)
- Common Human 5′ Dopamine Transporter (SLC6A3) Haplotypes Yield Varying Expression Levels In Vivo (2006) (50)
- Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study. (1995) (50)
- Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET (1997) (50)
- Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers. (1999) (48)
- Application of the nucleophilic substitution reaction to the synthesis of No‐carrier‐added [18F]fluorobenzene and other 18F‐labeled aryl fluorides (1984) (48)
- Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicyclo-[2.2.1]heptane: a new positron emission tomography ligand for nicotinic receptors. (1997) (48)
- Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors (2000) (47)
- Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain. (1995) (47)
- Dr. Volkow and Colleagues Reply (1987) (47)
- Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease (2007) (47)
- Nucleophilic addition-elimination reactions of 1,2-bis(p-tolylsulfonyl)ethene (1968) (47)
- Comparative studies of epibatidine derivatives [18F]NFEP and [18F]N-methyl-NFEP: kinetics, nicotine effect, and toxicity. (1999) (46)
- Synthesis of 15O-labeled butanol via organoborane chemistry. (1985) (46)
- Cocaine abusers do not show loss of dopamine transporters with age. (1997) (46)
- Effects of low-field magnetic stimulation on brain glucose metabolism (2009) (46)
- Alcohol intoxication induces greater reductions in brain metabolism in male than in female subjects. (2003) (46)
- Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. (2005) (45)
- Aromatase Imaging with [N-Methyl-11C]Vorozole PET in Healthy Men and Women (2015) (45)
- THE EFFECT OF TARGET-GAS PURITY ON THE CHEMICAL FORM OF 18F DURING 18F-F2 PRODUCTION USING THE NEON/FLUORINE TARGET (1980) (44)
- The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects (2005) (44)
- Ion chromatographic analysis of high specific activity 18FDG preparations and detection of the chemical impurity 2-deoxy-2-chloro-D-glucose. (1992) (44)
- A simple, rapid method for the preparation of [11C]formaldehyde. (2008) (44)
- Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors. (2014) (44)
- Comparison of high specific activity (-) and (+)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. (1993) (44)
- Dopamine Receptor‐Mediated Regulation of Striatal Cholinergic Activity (2000) (43)
- Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain. (2009) (43)
- Relationship between ethanol-induced changes in brain regional metabolism and its motor, behavioural and cognitive effects. (2004) (42)
- Synthesis of carbon-11, fluorine-18, and nitrogen-13 labeled radiotracers for biomedical applications. Nuclear Science Series: Nuclear Medicine (1982) (42)
- Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. (1982) (42)
- An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo. (1998) (42)
- PET imaging in clinical drug abuse research. (2005) (41)
- High Levels of Dopamine D 2 Receptors in Unaffected Members of Alcoholic Families (2006) (41)
- Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders? (2008) (41)
- Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain. (2000) (40)
- Alcohol Decreases Baseline Brain Glucose Metabolism More in Heavy Drinkers Than Controls But Has No Effect on Stimulation-Induced Metabolic Increases (2015) (40)
- MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. (1996) (40)
- Positron emission tomography in dementia. (1983) (40)
- Regional distribution and kinetics of haloperidol binding in human brain: A pet study with [18F]haloperidol (1992) (40)
- Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157 (2010) (39)
- Reproducibility of regional brain metabolic responses to lorazepam. (1996) (39)
- Nicotine Blocks Brain Estrogen Synthase (Aromatase): In Vivo Positron Emission Tomography Studies in Female Baboons (2010) (39)
- Anger and depression in cocaine addiction: association with the orbitofrontal cortex (2005) (38)
- Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects (2005) (38)
- In vivo comparative imaging of dopamine D2 knockout and wild-type mice with (11)C-raclopride and microPET. (2002) (38)
- Serial PET studies of human cerebral malignancy with [1-11C]putrescine and [1-11C]2-deoxy-D-glucose. (1987) (38)
- PET imaging of thin objects: measuring the effects of positron range and partial-volume averaging in the leaf of Nicotiana tabacum. (2011) (37)
- Thallium in organic synthesis. IX. Facile thallation of aromatic compounds with thallium(III) trifluoroacetate (1, 2)☆ (1969) (36)
- Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates. (2005) (36)
- Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain. (1996) (35)
- Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters (1996) (35)
- Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. (1995) (35)
- Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl and (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and positron emission tomography studies in baboon brain. (1990) (35)
- Differences in regional brain metabolic responses between single and repeated doses of methylphenidate (1998) (35)
- Positron Emission Tomography in Oncology (1988) (35)
- Neuropsychiatric disorders: investigation of schizophrenia and substance abuse. (1992) (35)
- Comparative PET studies of the kinetics and distribution of cocaine and cocaethylene in baboon brain (1992) (35)
- The Isomerization of a Vinyl Azide to a Triazole (1967) (35)
- Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats. (1978) (34)
- Distribution of tracer levels of cocaine in the human brain as assessed with averaged [11C]cocaine images (1999) (34)
- Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons. (1997) (34)
- Comparison of the binding of the irreversible monoamine oxidase tracers, [(11)C]clorgyline and [(11)C]l-deprenyl in brain and peripheral organs in humans. (2004) (34)
- Specific Binding of [11C]Spiroperidol in Rat Brain In Vivo (1983) (34)
- Synthesis and PET studies of [(11)C-cyano]letrozole (Femara), an aromatase inhibitor drug. (2009) (34)
- Age associated decrements in dopamine D2 receptors in thalamus and in temporal insula of human subjects. (1996) (34)
- PET imaging of monoamine oxidase B in peripheral organs in humans. (2002) (33)
- Altered glucose metabolism in microvessels from patients with Alzheimer's disease (1989) (33)
- Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine (1995) (33)
- Synthesis of the racemate and individual enantiomers of [11C]methylphenidate for studying presynaptic dopaminergic neuron with positron emission tomography (1994) (33)
- Radiopharmaceuticals. 12. A new rapid synthesis of carbon-11 labeled norepinephrine hydrochloride. (1974) (32)
- Non‐MAO A binding of clorgyline in white matter in human brain (2001) (32)
- Studies with Differentially Labeled [11C]Cocaine, [11C]Norcocaine, [11C]Benzoylecgonine, and [11C]‐and 4′‐[18F]Fluorococaine to Probe the Extent to Which [11C]Cocaine Metabolites Contribute to PET Images of the Baboon Brain (1994) (32)
- PET imaging studies in drug abuse. (1998) (32)
- Fluorination with F/sub 2/. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose (1977) (32)
- Methylphenidate decreases regional cerebral blood flow in normal human subjects. (1994) (32)
- Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches (2010) (31)
- Imaging the neurochemistry of nicotine actions: studies with positron emission tomography. (1999) (31)
- New-generation radiotracers for nAChR and NET. (2005) (31)
- Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using Positron Emission Tomography. (2010) (31)
- Synthesis of model compounds for maleylacetoacetic acid. Maleylacetone (1970) (31)
- Quantitative autoradiography of cocaine binding sites in human brain postmortem (1992) (31)
- The orbitofrontal cortex in methamphetamine addiction: involvement in fear (2002) (31)
- Serotonin and the therapeutic effects of ritalin. (2000) (31)
- Coupling between ammonium uptake and incorporation in a marine diatom: Experiments with the short‐lived radioisotope 13N (1988) (30)
- Pet studies of cocaine inhibition of myocardial norepinephrine uptake (1994) (30)
- 2-Deoxy-2-[18F]fluoro-D-glucose for metabolic studies: current status. (1986) (30)
- Synthesis of [18F]norchlorofluoroepibatidine and its N-methyl derivative: new PET ligands for mapping nicotinic acetylcholine receptors (1997) (30)
- Predominance of D2 Receptors in Mediating Dopamine's Effects in Brain Metabolism: Effects of Alcoholism (2013) (30)
- The synthesis of no-carrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction. (1991) (29)
- Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. (2005) (29)
- Potential Contribution of Aromatase Inhibition to the Effects of Nicotine and Related Compounds on the Brain (2012) (29)
- Gas‐liquid chromatographic determination of relative amounts of 2‐deoxy‐2‐flouro‐D‐glucose and 2‐deoxy‐2‐fluoro‐D‐mannose synthesized from various methods (1985) (29)
- Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drug. (1993) (29)
- Labelling of fluorinated aromatics by isotopic exchange with [18F]fluoride (1981) (29)
- Therapeutic doses of buspirone block D3 receptors in the living primate brain. (2014) (29)
- Mechanistic Positron Emission Tomography Studies of 6‐[18F]Fluorodopamine in Living Baboon Heart: Selective Imaging and Control of Radiotracer Metabolism Using the Deuterium Isotope Effect (1995) (28)
- Evidence that gingko biloba extract does not inhibit MAO A and B in living human brain. (2000) (28)
- Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions. (2000) (28)
- Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates. (1998) (28)
- Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain. (2013) (27)
- Dynamic Precision Phenotyping Reveals Mechanism of Crop Tolerance to Root Herbivory[OPEN] (2016) (27)
- Chapter 29. New Directions in Positron Emission Tomography (1989) (27)
- Species differences in [11C]clorgyline binding in brain. (2001) (27)
- Mapping brain neuroleptic receptors in the live baboon. (1984) (26)
- Radiotracers for positron emission tomography imaging. (2003) (26)
- Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase. (2009) (25)
- Strategy for the Formation of Parametric Images under Conditions of Low Injected Radioactivity Applied to PET Studies with the Irreversible Monoamine Oxidase a Tracers [11C]Clorgyline and Deuterium-Substituted [11C]Clorgyline (2002) (25)
- Occupancy of brain nicotinic acetylcholine receptors by nicotine doses equivalent to those obtained when smoking a cigarette (2000) (24)
- No-carrier-added aryl [18F]fluorides via the nucleophilic aromatic substitution of electron rich aromatic rings. (1990) (24)
- Synthesis and biodistribution of no-carrier-added [1-11C]putrescine. (1985) (24)
- Synthesis of carbon-11 labeled iodinated cocaine derivatives and their distribution in baboon brain measured using positron emission tomography. (1992) (24)
- Long‐term stability of neurotransmitter activity investigated with 11C‐raclopride PET (1998) (24)
- Metabolic studies of drugs of abuse. (1990) (24)
- In Vitro and Ex Vivo Autoradiographic Studies of Nicotinic Acetylcholine Receptors Using [18F]Fluoronorchloroepibatidine in Rodent and Human Brain (1998) (24)
- Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-D-glucose cerebral uptake in rodents through time. (2006) (23)
- Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector. (1993) (23)
- Monoamine oxidase A imaging in peripheral organs in healthy human subjects (2003) (22)
- Regional cerebral metabolism in female alcoholics of moderate severity does not differ from that of controls. (1998) (22)
- Synthesis and evaluation of fluorinated derivatives of fentanyl as candidates for opiate receptor studies using positron emission tomograpry (1986) (22)
- 18F-5-Fluorouridine, a new probe for measuring the proliferation of tissue in vivo. (1982) (22)
- Radiosynthesis of C-11 Labeled Auxin (3-Indolyl[1-11C]acetic Acid) and Its Derivatives from Gramine (2011) (22)
- Mapping catechol-O-methyltransferase in vivo: initial studies with [18F]Ro41-0960. (1995) (22)
- Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals. (1976) (22)
- What is in a word? No versus Yes differentially engage the lateral orbitofrontal cortex. (2007) (22)
- 18F-2-FLUORO-2-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY OF HUMAN CEREBRAL GLIOMAS (1981) (22)
- Removal of the 2.2.2 cryptand (Kryptofix 2.2.2) from 18FDG by cation exchange. (1991) (21)
- Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps. (1999) (21)
- Positron emission tomography - A new approach to brain chemistry (1988) (21)
- Thallium in organic synthesis. X. A one-step synthesis of aryl iodides☆ (1969) (21)
- MicroPET imaging in an animal model of anorexia nervosa (2005) (21)
- Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: a preliminary study. (1996) (20)
- Comparison of two PET radioligands for imaging extrastriatal dopamine receptorsin the human brain (1993) (20)
- Positron Emission Tomography Studies of Dopamine‐Enhancing Drugs (1999) (20)
- Intimate combination of low‐ and high‐resolution image data: I. real‐space PET and 1H2O MRI, PETAMRI (1999) (20)
- The Use of Alternative Forms of Graphical Analysis to Balance Bias and Precision in PET Images (2010) (19)
- Synthesis and preliminary evaluation in animals of carrier-free 11C-1-dopamine hydrochloride: X. (1973) (19)
- Cocaine is pharmacologically active in the nonhuman primate fetal brain (2010) (19)
- Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain. (2001) (19)
- Selegiline potentiates cocaine‐induced increases in rodent nucleus accumbens dopamine (2003) (19)
- 2-Methyl-3-butyn-2-ol as an acetylene precursor in the Mannich reaction. A new synthesis of suicide inactivators of monoamine oxidase. (1977) (19)
- Evaluation of gender difference in regional brain metabolic responses to lorazepam (1998) (18)
- In Vivo Imaging of Brain Aromatase in Female Baboons: [11C]Vorozole Kinetics and Effect of the Menstrual Cycle (2013) (18)
- Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels. (1987) (18)
- Radioisotope scintigraphy for the study of dynamics of amine regulation by the human lung. (1977) (18)
- A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET. (1991) (18)
- Reactions to Media Violence: It’s in the Brain of the Beholder (2014) (18)
- Synthesis of L-[5-11C]ornithine. (1989) (18)
- Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging. (2018) (18)
- A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET. (1986) (17)
- High-resolution circular ring positron tomograph with dichotomic sampling: Dichotom-I (1983) (17)
- Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [11C]GSK189254 in anesthetized baboon (2012) (17)
- Direct approach for attenuating cocaine's effects on extracellular dopamine: Targeting the dopamine transporter (1997) (17)
- Increased activity of the temporal insula in subjects with bradycardia. (2000) (17)
- Radiopharmaceuticals. XIX. 11C-labeled octylamine, a potential diagnostic agent for lung structure and function. (1976) (17)
- Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug. (2007) (16)
- A simple one-pot synthesis of cyclopropane [11C]carbonyl chloride. Synthesis and biodistribution of [11C]cyclorphan† (1986) (16)
- Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder (2019) (16)
- Polymer-supported organotin reagent for prosthetic group labeling of biological macromolecules with radioiodine. (2011) (16)
- Deuterium Micromapping of Biological Samples by Using the D(T,n)4He Reaction and Plastic Track Detectors (1974) (16)
- Visualization of monoamine oxidase in human brain. (1996) (16)
- Long‐lasting inhibition of in vivo cocaine binding to dopamine transporters by 3β‐(4‐Iodophenyl)Tropane‐2‐Carboxylic acid Methyl Ester: RTI‐55 or βCIT (1995) (16)
- A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone (2001) (16)
- Efficient synthesis and formulation of (R)-(−)-[11C]Deprenyl, a selective radioligand for the quantification of MAO-B activity using PET (2002) (15)
- Rapid radiosynthesis of [11C] and [14C]azelaic, suberic, and sebacic acids for in vivo mechanistic studies of systemic acquired resistance in plants (2012) (15)
- Investigation of SN2 [11C]cyanation for base-sensitive substrates: an improved radiosynthesis of l-[5-11C]-glutamine (2015) (15)
- Photolysis and pyrolysis of trans-azidovinyl p-tolyl sulfone (1968) (15)
- A novel 123I-labeling reagent. XIII. Synthesis and loading-dose effects of 123I-iodophenylalanine and 123I-5- and6-iodotryptophan. (1974) (15)
- The MAO-A genotype does not modulate resting brain metabolism in adults (2008) (14)
- Positron Emission Tomographic Evidence of Similarity Between Obesity and Drug Addiction (2003) (14)
- Haloperidol blocks the uptake of [18F]N‐methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients (1995) (14)
- Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography (1988) (14)
- Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel. (1988) (14)
- New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain (2017) (14)
- Evaluation of positron emission tomography as a method to visualize subsurface microbial processes. (2012) (14)
- Positron emission tomography. Biomedical research and clinical application. (1995) (14)
- Rapid, regiospecific syntheses of deuterium substituted 6‐[18F]fluorodopamine (α,α‐D2; β,β‐D2 and α,α,β,β‐D4) for mechanistic studies with positron emission tomography (1993) (13)
- Modular automation in PET tracer manufacturing: application of an autosynthesizer to the production of 2-deoxy-2-[18F]fluoro-D-glucose. (1986) (13)
- Is [1-11C]putrescine useful as a brain tumor marker? (1992) (13)
- An efficient and practical synthesis of [2-(11)C]indole via superfast nucleophilic [(11)C]cyanation and RANEY® Nickel catalyzed reductive cyclization. (2015) (13)
- Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex (2003) (13)
- Evaluation of radiorespirometry for the determination of monoamine oxidase activity in vivo utilizing [11C]octylamine as a substrate. (1977) (13)
- Kinetic Analysis of [11C]Vorozole Binding in the Human Brain with Positron Emission Tomography (2014) (13)
- Alcohol Intoxication Induces Greater Reductions in Brain Metabolism in Male Than in Female Subjects (2003) (12)
- METABOLIC MAPPING OF FUNCTIONAL CEREBRAL ACTIVITY IN MAN USING THE 18F-2-FLUORO-2-DEOXYGLUCOSE TECHNIQUE (1978) (12)
- National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
- Pharmacology of Cocaine (1998) (12)
- Positron emission tomography and its use to image the occupancy of drug binding sites (2003) (12)
- Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers. (2005) (11)
- Comparison of Brain Glucose Metabolism and Monoamine Oxidase B (MAO B) in Traumatic Brain Injury. (1999) (11)
- 2-deoxy-2-[18F]fluoro-D-glucose and alternative radiotracers for positron emission tomography imaging using the human brain as a model. (2004) (11)
- Overlapping Neuronal Circuits in Addiction and Obesity (2011) (11)
- Brain-imaging studies of the combined use of cocaine and alcohol and of the pharmacokinetics of cocaethylene. (1994) (11)
- Reactions of 2-Naphthol with N-Piperidine-methyl and N-Morpholinomethyl Alkyl Ethers. (1963) (11)
- Serotonin 5-HT2 receptor availability in chronic cocaine abusers. (1995) (11)
- Investigations of acetonitrile solvent cluster formation in supercritical carbon dioxide, and its impact on microscale syntheses of carbon-11-labeled radiotracers for PET. (1999) (11)
- Resting brain metabolic activity in a 4 Tesla magnetic field (2000) (11)
- Synthesis and decomposition of alkyl nitronic esters of 2,6-di-tert-butyl-4-nitrophenol (1968) (10)
- Inhibition of food craving is a metabolically active process in the brain in obese men (2019) (10)
- Synthesis of radiopharmaceuticals and labeled compounds utilizing short- lived isotopes (1972) (10)
- Relationship of estrogen synthesis capacity in the brain with obesity and self-control in men and women (2020) (10)
- Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism (2013) (10)
- Displacement of RTI-55 from the dopamine transporter by cocaine. (1996) (10)
- Chapter 28. New Directions in Positron Emission Tomography-Part II (1990) (10)
- [18F]haloperidol binding in baboon brain in vivo. (1996) (10)
- Tetraethylene glycol promoted two-step, one-pot rapid synthesis of indole-3-[1-11C]acetic acid (2015) (9)
- Determination of the enantiomeric composition of samples of cocaine by normal-phase high-performance liquid chromatography with UV detection. (1992) (9)
- Production of H18F by Deuteron Irradiation of a Neon-Hydrogen Gas Target (1983) (9)
- Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone. (1985) (9)
- Use of positron emission tomography to study cocaine in the human brain. (1991) (9)
- Decreased striatal and enhanced thalamic dopaminergic responsivity in detoxified cocaine abusers (1997) (8)
- ANHYDROUS 18F LABELED ELEMENTAL FLUORINE FOR RADIOPHARMACEUTICAL PREPARATION (1981) (8)
- The flash vacuum thermolysis of (-)-cocaine (1989) (8)
- Production and use of cobalt-55 as an antibody label for PET imaging (1994) (8)
- Mechanistic pet studies demonstration of a deuterium isotope effect in the mao catalyzed binding of carbon 11 l deprenyl in living baboon brain (1987) (8)
- Evaluation of Regional Glucose Metabolism with Positron Emission Tomography in Normal and Psychiatric Populations (1983) (8)
- Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine. (1994) (7)
- Organic radiopharmaceuticals: recent advances (1979) (7)
- Reaction of hindered phenols with diazomethane (1968) (7)
- The design and performance of a portable handheld (11)CO2 delivery system. (2014) (7)
- Highlights of PET studies on chiral radiotracers and drugs at Brookhaven (2003) (7)
- Mechanism of nitrogen-13-labeled ammonia formation in a cryogenic water target. (1999) (7)
- Human Cognitive Ability Is Modulated by Aromatase Availability in the Brain in a Sex-Specific Manner (2020) (7)
- New synthesis of unsymmetrical azo compounds (1972) (7)
- The heritage of radiotracers for positron emission tomography. (1990) (7)
- maging the Effects of Methylphenidate on Brain opamine: New Model on Its Therapeutic Actions for ttention-Deficit/Hyperactivity Disorder (2005) (7)
- Synthesis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging. (2003) (7)
- Neuroimaging of Addiction (2014) (7)
- Decreased brain dopaminergic responses in active cocaine dependent subjects (2010) (7)
- Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. (2008) (7)
- Cardiotoxic properties of cocaine: studies with positron emission tomography. (1996) (7)
- Improvements in the production of [18F]N‐methylspiroperidol and [18F]haloperidol (1989) (6)
- Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase. (2015) (6)
- Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureus. (2014) (6)
- Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors. (2000) (6)
- Regional Distribution of Aromatase in the Human Brain (2012) (6)
- Synthesis of 3H- and 14C-labeled tracers for studies of functional monoamine oxidase activity (1988) (6)
- The synthesis of 14C‐labeled suicide inactivators of monoamine oxidase (1978) (6)
- Design and Synthesis of 2‐Deoxy‐2‐[18F]Fluoro‐D‐Glucose (18FDG) (2005) (6)
- Synthesis of l-[4-11 C]Asparagine by Ring-Opening Nucleophilic 11 C-Cyanation Reaction of a Chiral Cyclic Sulfamidate Precursor. (2018) (5)
- A mild, rapid synthesis of freebase [11C]nicotine from [11C]methyl triflate. (2016) (5)
- Kinetics of the Reaction of Nitroalkanes with Methylenebispiperidine. A Study of the Mannich Reaction (1965) (5)
- Instrumentation in Positron Emission Tomography (1988) (5)
- The evaluation of the lumped constant for deoxyglucose and fluorodeoxyglucose in man (1984) (5)
- Substituent effects on ferrocenes in aluminum chloride-butylpyridinium chloride molten-salt mixtures (1990) (5)
- Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter. (2012) (5)
- [(11)C]PR04.MZ, a promising DAT ligand for low concentration imaging: Synthesis, efficient (11)C-O-methylation and initial small animal PET studies. (2009) (5)
- Alcohol intoxication does not change [11C]cocaine pharmacokinetics in human brain and heart. (1992) (5)
- 18FDG for the Study of Central Nervous System Drugs (2001) (5)
- Cryogenic target design considerations for the production of [18F]fluoride from enriched [18O]carbon dioxide. (1999) (5)
- Rapid synthesis of [18F]SR46349B, a potent and selective 5‐HT2 receptor antagonist (1995) (5)
- PET studies of peripheral catechol-O-methyltransferase in non-human primates using [18F]Ro41-0960 (1998) (5)
- Deprenyl and levodopa and Parkinson's disease progression (1996) (5)
- Radiosynthesis of 3-indolyl[1-¹¹C]acetic acid for phyto-PET-imaging: an improved production procedure and formulation method. (2014) (5)
- Induced magnetic force in human heads exposed to 4 T MRI (2010) (4)
- Kinetics of the Reaction of 2-Nitropropane with Methylenebisamines. A Study of the Mannich Reaction (1964) (4)
- Tissue distributions of radiopharmaceuticals labeled with positron emitters and problems in relating them to human studies (1983) (4)
- Addiction Circuitry in the Human Brain (2015) (4)
- In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronochloroepibatidine in rodent and human brain. (1998) (4)
- PET Studies of the Effect of the Antidepressant Drugs Nefazodone or Paroxetine on [11C]Raclopride Binding in Human Brain. (1999) (4)
- In vivo evaluation of [11C]CNS-5161 as a use-dependent ligand for the NMDA glutamate receptor channel (2005) (4)
- 103 APPLICATION OF IMAGING TECHNOLOGIES IN THE INVESTIGATION OF DRUG ADDICTION (2002) (4)
- Design and Synthesis of 2-Deoxy-2-[ 18 F ] fluoro-D-glucose ( 18 FDG ) (2001) (4)
- 18F-Labeled Tracers for Positron Emission Tomography Studies in the Neurosciences (1996) (4)
- Synthesis and pet studies of [11C]D- and [11C]L-boronophenylalanine for improving BNCT in brain tumors (2001) (4)
- Dopamine Deficiency, Eating, and Body Weight (2012) (4)
- Carbon‐11 labeled (±)‐ and (‐)‐ketamine: Synthesis and PET studies in a baboon (1989) (3)
- Synthesis of 2-deoxy-D-(1-/sup 11/C)glucose for regional metabolic studies: concise communication (1981) (3)
- Total cyanide mass measurement with micro-ion selective electrode for determination of specific activity of carbon-11 cyanide. (2015) (3)
- A simple, rapid method for the preparation of [ 11 C]formaldehyde ** (2008) (3)
- RADIOPHARMACEUTICALS PART 12, A NEW RAPID SYNTHESIS OF CARBON-11 LABELED NOREPINEPHRINE HYDROCHLORIDE (1974) (3)
- Therapeutic doses of buspirone block D3 receptors in the living primate brain – CORRIGENDUM (2014) (3)
- Neurochemical mechanisms underlying responses to psychostimulants. (1996) (3)
- Assessment of regional glucose metabolism in aging brain and dementia with positron-emission tomography (1981) (3)
- Peripheral insulin resistance affects brain dopaminergic signaling after glucose ingestion (2013) (3)
- A non-invasive LSO-APD blood radioactivity monitor for PET imaging studies (2002) (3)
- Radiosynthesis of the fluorinated sucrose analogue, 1′-[18F]fluoro-1′-deoxysucrose (2012) (3)
- Reply to Burgard: Gender differences in eating behaviors and obesity (2009) (2)
- Neuroimaging and Substance Abuse (2003) (2)
- The dopamine hypothesis of ADHD and brain response to stimulant medication. (2013) (2)
- New improved synthesis of 2-deoxy-2-(/sup 18/F)fluoro-d-glucose from /sup 18/F-labeled acetyl hypofluorite (1982) (2)
- Synthesis and positron emission tomographic (PET) baboon studies of [{sup 11}C]methadone and R-(-)-[{sup 11}C]methandone (1996) (2)
- A fluorimetric assay of the phosphoribosylation of 6-mercaptopurine in human blood cells. (1979) (2)
- Discovery of Highly Potent Adenosine A1 Receptor Agonists: Targeting Positron Emission Tomography Probes. (2021) (2)
- Medical autoradiography with stable isotope thymidine: theory and preliminary experiments (1973) (2)
- Imaging Studies in Substance Abuse (2003) (2)
- Carrier-free $sup 11$C-labeled catecholamines in nuclear medicine and biochemical research (1973) (2)
- In vivo distribution of human brain aromatase with [11C]vorozole (2010) (2)
- Development of robotic plasma radiochemical assays for positron emission tomography (1995) (2)
- Methylphenidate improves the efficiency of the human brain (2008) (2)
- CT, PET AND NUR BRAIN IMAGING IN AGING AND ALZHEIMERʼS DISEASE (1984) (2)
- Recent advances in the chemistry of positron emitters (1985) (2)
- Small cyclotrons and the production of positron emitters: present and future (1984) (2)
- Probing the biochemical basis of the PET image. Mechanistic PET studies of [11C]L-deprenyl binding using the deuterium isotope effect (1989) (2)
- Synthesis and PET studies of [11C]letrozole, an aromatase inhibitor drug (2008) (2)
- Fluorine-18 labeled tracers for PET studies in the neurosciences (1995) (2)
- Brain Imaging and Addiction (2010) (2)
- Brain imaging studies of the cocaine addict: Implications for reinforcement and addiction (1995) (2)
- 18F-FDG Radiosynthesis: A Landmark in the History of PET. (2020) (2)
- Decreased striatal dopaminergic responsivity in alcoholic subjects (2007) (2)
- Saturable, non-aromatase binding of [11C]vorozole in baboon liver (2011) (2)
- Substituent effects on alkylferrocenes in molten salt mixtures (1989) (2)
- Measuring dopamine release in the human brain with PET (1995) (2)
- Decreased brain aromatase availability in overweight humans (2011) (2)
- Imaging Monoamine Oxidase in the Human Brain (1999) (2)
- New developments in radiotracers for positron emission tomography. (1991) (2)
- Labeled Compounds for Positron Emission Tomography (1983) (2)
- Gene-brain-behavior relationships: Evidence that aggression is associated with brain MAO A activity in healthy males (2007) (1)
- Synthesis of 11C-compounds including double isotopic labelling: Some perspectives (1988) (1)
- Comparison of [11C]cocaine binding at tracer and pharmacological doses of baboon brain: A PET study (1994) (1)
- PET IMAGING STUDIES IN DRUG ABUSE RESEARCH. (2001) (1)
- Exploring the links between the brain dopamine transporter availability, DAT1 genotype and body mass index (2012) (1)
- Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate (2010) (1)
- 33. Dopaminergic modulation of frontal activity: Involvement in cocaine addiction (1996) (1)
- Rapid radiochemical and chemical quality control of [11C]putrescine. (1993) (1)
- Kinetic analysis of [11C]vorozole binding in the human brain with positron emission tomography. (2014) (1)
- PET in drug research and development (1992) (1)
- PET studies of [18F]norchlorofluoroepibatidine in mapping nicotinic acetylcholine receptors (nAChR) (1996) (1)
- GABAERGIC MODULATION OF ENDOGENOUS NEUROTRANSMITTER RELEASE MEASURED IN VIVO WITH POSITRON EMISSION TOMOGRAPHY. (1992) (1)
- Naloxone’s dose-dependent displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain (2022) (1)
- The value of "the putrescine experience". (1992) (1)
- Determination of glucose metabolism of brain tumors and adjacent normal brain tissue and their early response to radiotherapy by f-18 fluorodeoxglulose position emission tomography (FDG-pet scan) (1994) (1)
- Synthesis of (/sup 18/F)-5-fluorouridine (F-18-5-FUR) as a probe for measuring RNA synthesis and tumor growth rates in vivo (1979) (1)
- A FluorinatedGlucose Analog, 2-fluoro-2-deoxy-D-glucose(F-18): Nontoxic Tracer for RapidTumor Detection (2006) (1)
- Gender Differences in Brain Activation by Food Stimulation (2011) (1)
- Diels-Alder reaction of N-vinylphthalimide with isoprene and 9-methoxyanthracene (1970) (1)
- Imaging the Brain Dopamine Transporter Using PET and SPECT (2002) (1)
- Special characteristics and potential for radiotracers for positron emission tomography. (1981) (1)
- A comparison of (/sup 18/F)spiroperidol, (/sup 18/F)benperidol and (/sup 18/F) haloperidol kinetics in baboon brain (1984) (1)
- Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of exo‐2‐(2′‐Fluoro‐5′‐pyridinyl)‐7‐azabicyclo(2.2.1)heptane: A New Positron Emission Tomography Ligand for Nicotinic Receptors. (1997) (1)
- Hot cell for the synthesis of labelled organic compounds (1979) (1)
- Synthesis and evaluation of the racemate and individual enantiomers of C-11 labeled methylphenidate as radioligands for the presynaptic dopaminergic neuron (1994) (1)
- N-(3-Fluoropropyl)-N-normetazocine, a potentially useful opiate antagonist for opiate receptor studies with positron emission tomography (PET). (1985) (1)
- Naloxone’s displacement of [11C]carfentanil and duration of receptor occupancy in the rat brain: implications for opioid overdose reversal (2022) (1)
- 2-METHYL-3-BUTYN-2-OL AS AN ACETYLENE PRECURSOR IN THE MANNICH REACTION. A NEW SYNTHESIS OF SUICIDE INACTIVATORS OF MONOAMINE OXIDASE (1977) (1)
- High-resolution circular ring positron tomograph with dichotomic sampling: Dichotom-I. (1984) (1)
- Histone Deacetylase Inhibitor MS-275 Exhibits Poor Brain Penetration: Pharmacokinetic Studies of [ 11 C]MS-275 using Positron Emission Tomography (2009) (1)
- Cyclotrons and Positron Emitting Radiopharmaceuticals (1987) (1)
- Recovery of dopamine transporter loss after protracted abstinence in methamphetamine users (2009) (1)
- Short-lived positron emitter labeled radiotracers - present status (1982) (1)
- Radiolabelling of novel enoyl-ACP reductase inhibitors for non-invasive imaging of Staphylococcus aureus infection in mice using PET (2013) (0)
- No-carrier-added (/sup 18/F)-N-methylspiroperidol (1985) (0)
- Dopamine transporter occupancy by RTI-55 determined using labeled cocaine, and displacement of RTI-55 with unlabeled cocaine (1995) (0)
- Fowler awarded National Medal of Science. (2009) (0)
- Imaging Brain Chemistry in Diseases of Addiction (2010) (0)
- Quantitating aromatase in the human brain with PET and [N-methyl-11C]vorozole([11C]VOR) (2010) (0)
- A solid phase approach for radioiodination of iodobenzoic acid from a tin precursor for nuclear medicine applications (2010) (0)
- Synthesis of carbon-11 and fluorine-18 labeled 4-fluorodeprenyl as probes for functional monoamine oxidase. (1989) (0)
- Quantitative Autoradiographic Localization and Characterization of Cocaine Binding Sites in the Human Brain Post-Mortem (2020) (0)
- Response (1990) (0)
- Effect of age on extrastriatal dopamine D2 receptor availability (1996) (0)
- Images in neuroscience. Neuroimaging, XI. PET and pharmacodynamics. (1996) (0)
- Enhanced regional brain metabolic responses to benzodiazepines in cocaine abusers (1997) (0)
- Use of supercritical carbon dioxide fluid as a solvent for the purification of pet radiotracers (1993) (0)
- Accelerator produced nuclides for use in biology and medicine. A bibliography, 1939--1973 (1975) (0)
- Human PET studies of the norepinephrine transporter (NET) with (S,S)-[11C]O-methyl reboxetine ([11C](S,S)-MRB) and PET (2007) (0)
- Nuclear medicine and chemistry. (2002) (0)
- New genetic marker in the AKT1 gene predicts DRD2 levels in human brain (2013) (0)
- in brain reward circuitry Gastric stimulation in obese subjects activates the hippocampus and other regions involved (2006) (0)
- Methamphetamine pharmacokinetics in human brain: Comparison with cocaine (2008) (0)
- Quantitative Macroautoradiography for the Study of Radiopharmaceutical s with Special Reference to Positron-Emitting Compounds (1982) (0)
- Neuroimaging studies in an animal model of toluene abuse (2006) (0)
- Local cerebral glucose utilization measured with 18F-2-fluoro-2-deoxyglucose (1978) (0)
- Differential uptake of 2-fluoro-2-deoxy-D-glucose. (1983) (0)
- A Conversation Between Joanna Fowler and Johannes Czernin (2019) (0)
- Cognitive control over craving in cocaine abusers decreased metabolism in right ventral striatum and medial orbitofrontal cortex (2009) (0)
- Richard M. Lambrecht (2002) (0)
- Synthesis and positron emission tomography (PET) study of C-11 labeled Gleevec(R) (imatinib) (2006) (0)
- No-carrier-added [1.sup.11 c]putrescine (1989) (0)
- Rapid synthesis of carrier free $sup 11$C-dopamine hydrochloride (1975) (0)
- RADIOPHARMACEUTICALS. 16. HALOGENATED DOPAMINE ANALOGS. SYNTHESIS AND RADIOLABELING OF 6-IODODOPAMINE AND TISSUE DISTRIBUTION STUDIES IN ANIMALS (1976) (0)
- Enzyme-aided synthesis of a radiofluorinated dissacharide sugar (2013) (0)
- Labeling of SR 46349B, a potent and selective 5-HT{sub 2} receptor antagonist (1995) (0)
- Novel $sup 123$I-labeling reagent. XIII. Synthesis and loading-dose effects of $sup 123$I-4-iodophenylalanine and $sup 123$I-5- and 6-iodotryptophan (1974) (0)
- PET Studies of Zelapar (2011) (0)
- Use of PET to Study Addiction in Humans (2017) (0)
- Addiction Studies with Positron Emission Tomography (2008) (0)
- Positron Emission Tomography (PET) and Graphical Kinetic Data Analysis of the Dopamine Neurotransmitter System: An Exercise for an Undergraduate Laboratory Course. (2014) (0)
- Carbon-ii-d-threo-MethylphenidateBinding to Dopamine Transporterin Baboon Brain (1995) (0)
- WITHDRAWN: Common brain mechanisms in addiction and obesity (2006) (0)
- Imaging receptors and their interactions: Implications for psychiatry (1989) (0)
- PET measurement of C-11-methylphenidate pharmacokinetics and distribution in the human brain (1994) (0)
- Receptor ligand studies using pet (1991) (0)
- PET studies of drugs affecting monoamine systems (1992) (0)
- Radiotracers for PETT: new developments and perspectives (1983) (0)
- Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [11C]GSK189254 in anesthetized baboon (2012) (0)
- PET studies with low and high affinity dopamine D2 receptor radioligands: Effects of 4-hydroxybutyrate (4HB) (1994) (0)
- BIOCHEMICAL STUDIES WITH THE PET RADIOTRACER F‐18 N‐METHYLSPIROPERIDOL (NMS). (1992) (0)
- Evidence that modafinil blocks the brain dopamine transporter and decreases dopamine D2 receptor availability in humans (2008) (0)
- Molecular Imaging: PET (2015) (0)
- Comparison of [{sup 11}C]d-threo-methylphenidata for assessing dopamine transporter (DAT) occupancy by cocaine (1997) (0)
- Expectation affects brain dopamine responses to methylphenidate in non-drug abusing subjects (2011) (0)
- Current BER Scientists: Principal Investigators (2001) (0)
- Model studies using supercritical carbon dioxide fluid (SF CO{sub 2}) as a reaction medium for radiotracer synthesis and purification (1994) (0)
- The spectrum of FDG-PET changes in brain glucose metabolism from normal aged to pathologically verified dementia subjects (2007) (0)
- Binge eating is associated with increases in extracellular dopamine during food stimulation (2008) (0)
- Dopamine function during early withdrawal predicts recovery in methamphetamine users (2009) (0)
- SYNTHESIS OF C-11-COMPOUNDS INCLUDING DOUBLE ISOTOPIC LABELING - SOME PERSPECTIVES (1988) (0)
- Drug pharmacokinetics and pharmacodynamics: Technological considerations (1992) (0)
- Synthesis and biodistribution of (C-11) labeled irreversible inhibitors of MAO A and B (1985) (0)
- PET Studies of CX-157 (2008) (0)
- [F-18]norchlorofluorepibatidine (NFED): Preclinical toxicological studies (1996) (0)
- Pharmacokinetics of [11C]-labeled aminoalkylindole derivatives for PET imaging of cannabinoid CB1 receptors in baboons (2008) (0)
- Cooperative Research and Development Agreement (CRADA) for Bio Imaging Research & Development Consortium between State University of New York at Stony Brook (SBU) and Brookhaven National Laboratory (BNL) (2014) (0)
- Determination of the lumped constant and the kinetic constants for deoxyglucose and fluorodeoxyglucose in man (1985) (0)
- Relationship between dopamine transporter occupancy and methylphenidate induced high in humans (1996) (0)
- Effect of target-gas purity on the chemical form of F-18 during /sup 18/F-F/sub 2/ production using the neon/fluorine target (1980) (0)
- Pet studies of monoamine oxidase B (MAO B) (1992) (0)
- Radiotracer Synthesis and PET Imaging Evaluation for Brain Histamine Receptors (2014) (0)
- A 4×4 pixilated Silicon Photomultiplier for a multi-channel radiation monitoring (2013) (0)
- Radiopharmaceuticals in PET, progress and promise (1988) (0)
- Improved sensitivity of human brain MAO B measurement using deuterium substituted [{sup 11}C]L-deprenyl ([{sup 11}C]L-deprenyl-D2) (1995) (0)
- Proof-of-concept in vivo PET studies to evaluate inhibition of brain aromatase binding of [11C]vorozole by nicotine administration in female baboons (2010) (0)
- POSITRON EMISSION TOMOGRAPHY (PET) AND COMPUTED TOMOGRAPHY (CT) EVALUATIONS COMBINED IN THE STUDY OF SENILE DEMENTIA OF THE ALZHEIMERʼS TYPE (1983) (0)
- 4 @bullet S C I E N C E & P R a C T I C E P E R S P E C T I V E S — a P R I L 2 0 0 7 (2007) (0)
- Is [l-nC]Putrescine Useful as a Brain Tumor Marker? (2006) (0)
- Hot cell for synthesis of labeled organic compounds (1979) (0)
- In Vivo Measurement of Transport and Metabolic Processes Using Radiotracers * (2021) (0)
- Nuclear medicine chemistry. (2001) (0)
- Radiotracer chemistry in 2002. (2003) (0)
- Use of the PETT III at brookhaven in metabolic and imaging studies with 18F-fluorodeoxyglucose and other compounds (1978) (0)
- Divergent associations between MAO A genotype on anterior cingulate metabolism, MAO A levels and cognitive control (2006) (0)
- Synthesis of (R)-5-(6-[18F]fluoropyridin-2-yl)-N-(quinuclidin-3-yl)thiophene-2-carboxamide for evaluation as a selective {alpha}7 nAChR PET tracer (2008) (0)
- Methylphenidate attenuates brain metabolic activation patterns induced by cocaine cues in cocaine abusers (2010) (0)
- No-carrier-added [111 c]putrescine (1990) (0)
- Evaluation of 11C [N-methyl-11C]vorozole ([11C]VOR) binding in human liver with PET (2012) (0)
- Brain Imaging and Addiction Neuroscience and Biobehavioral Psychology (2016) (0)
- Imaging retrograde transport and expression of D2 receptors after striatal gene transfer (2005) (0)
- Imaging of carcinoid tumors with PET and [C-11]clorgyline (2006) (0)
- Fowler Receives de Hevesy Nuclear Pioneer Award. (2017) (0)
- Plasma protein binding as a determinant of brain extraction—radiohalogenated cocaines (1992) (0)
- [{sup 11}C]d-threo-Methylphenidate, a new radiotracer for the dopamine transporter. Characterization in baboon and human brain (1995) (0)
- Slow Onset Inhibitors of Bacterial Fatty Acid Biosynthesis: Residence Time, In Vivo Activity and In Vivo Imaging (2010) (0)
- Distribution of methamphetamine in the human body: Ethnic effects (2010) (0)
- Recent Advances in Radiotracers for Pet Studies of the Brain (2021) (0)
- Sex difference in brain metabolic response to cognitive inhibition during food presentation (2007) (0)
- (/sup 11/C)clorgyline and (/sup 11/C)-L-deprenyl and their use in measuring functional monoamine oxidase activity in the brain using positron emission tomography (1986) (0)
- PET and SPECT Imaging in Substance Abuse Research (2011) (0)
- Implications Transporters in the Male Human Brain : Clinical Effects of Modafinil on Dopamine and Dopamine (2009) (0)
- Comparison of the brain pharmacokinetics of C-11 labeled isotopomers and metabolites of GTS-21, a partial {alpha}7 nicotinic agonist drug, with PET (2007) (0)
- Decreased dopamine D2 receptors and transporter in spontaneously obese bonnet macaques (2008) (0)
- PET Studies of Cocaine in Human Brain (2020) (0)
- Brain satiety circuit activated by gastric stimulation (2006) (0)
- Contents of the American Journal of Psychiatry (1993) (0)
- SYNTHESISAND PRELIMINARY EVALUATION IN ANIMALS OF (1973) (0)
- Pharmacokinetics and pharmacodynamics of the potent hallucinogen, salvinorin A (2008) (0)
- Effects of acute alcohol exposure on [11C]acetate uptake in the human brain (2012) (0)
- Comparison of methods for evaluating aromatase (AR) in the human brain with PET and [N-methyl-11C]vorozole ([11C]VOR) (2011) (0)
- FDG for the Study of Central Nervous System Drugs (2001) (0)
- Molecular Imaging: Positron Emission Tomography (2016) (0)
- Understanding Neuropsychiatric Disorders: Neuroimaging of obesity (2010) (0)
- Comparison of radiation dosimetry estimates for [11C]L-Deprenyl and [11C]Clorgyline across species and with D for H isotopic substitution. (2016) (0)
- Investigation of SN2 [11C]cyanation for base-sensitive substrates: an improved radiosynthesis of l-[5-11C]-glutamine (2014) (0)
- Decreased brain responses during cognitive inhibition of food craving elicited by food stimulation in obese subjects (2009) (0)
- THE USE OF PETT III AT BROOKHAVEN (1978) (0)
- Sleep deprivation decreases striatal D2R availability without increasing dopamine (2012) (0)
- Dopamine D-2 receptor-mediated regulation of central cholinergic activity: PET studies with [F-18]fluoroepibatidine (1997) (0)
- The heritage of radiotracers for PET (1988) (0)
- Automated GMP production of [11C]PR04.MZ via the captive solvent method and PET studies in non-human primates: A promising tracer for extrastriatal DAT imaging (2010) (0)
- Positron Emission Tomography, Enzymes and Drug Research and Development (1993) (0)
- Imaging the Distribution of Carbon‐11 Labeled Rifampicin, Isoniazid and Pyrazinamide in Baboons using PET (2010) (0)
- Correction to Alia-Klein et al. (2009). (2009) (0)
- Functional imaging of the brain with/sup 18/F-fluorodeoxyglucose (1980) (0)
- Is MRI-PET coregistration required for quantification of striatal dopamine receptors? (1995) (0)
- Comparison of the brain pharmacokinetics (PK) of different derivatives of 11C-labeled TZTP for imaging muscarinic M2 receptors (2007) (0)
- PET Studies of HT-0712 (2013) (0)
- One-night sleep deprivation decreases striatal and thalamic dopamine D2 receptor availability: Association with impaired cognitive performance and fatigue (2008) (0)
- Dopamine TransportersDecrease with Age (1996) (0)
- Decomposition as a Consequence of High Specffic Activity and High Dose Levels (2006) (0)
- PET Study of Light and Transcorneal Electrical Stimulation in Humans (2009) (0)
This paper list is powered by the following services:
Other Resources About Joanna Fowler
What Schools Are Affiliated With Joanna Fowler?
Joanna Fowler is affiliated with the following schools:
